Overview

A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected Surgeries

Status:
RECRUITING
Trial end date:
2026-01-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness, safety, and tolerability of SUZ for acute pain after laparoscopic procedures of the intraperitoneal or retroperitoneal cavities or arthroscopic orthopedic procedures.
Phase:
PHASE4
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated